KMG Chemicals, Inc. (NYSE: KMG), a global provider of specialty
chemicals, today announced financial results for the fiscal 2016 first
quarter ended October 31, 2015.
2016 First Quarter Financial Highlights
-
Adjusted EBITDA1 was a record $11.4 million, compared to
$8.8 million in last year’s first quarter.
-
Adjusted diluted earnings per share2 was a record $0.42, up
from $0.24 per share in the prior year’s first quarter.
-
GAAP EPS was $0.39 versus $0.10 in the first quarter of fiscal 2015.
Chris Fraser, KMG chairman and chief executive officer, said, “Building
on the progress we achieved in fiscal 2015, KMG reported strong first
quarter results. Adjusted EBITDA rose 30% to a record $11.4 million,
marking our seventh consecutive quarter of double-digit adjusted EBITDA
growth on a year-over-year basis, and adjusted EPS grew 75% compared to
the prior year.”
Mr. Fraser continued, “Excluding the effect of foreign currency, our
Electronic Chemicals sales increased 4% from the year-ago period,
benefiting from our global distribution capabilities and our focus on
supplying the highest purity products for our semiconductor customers’
most advanced manufacturing processes. Higher shipment volume and
improved efficiencies resulting from the consolidation of our global
operations continued to positively impact our profitability. Our penta
business performed solidly in the first quarter, driven by increased
volume from utility pole replacement programs in the western U.S. and
enhanced margins from favorable raw materials costs. Our industrial
lubricants business continues to contribute to our sales and earnings.”
|
|
|
|
|
|
|
|
|
|
|
First Quarter Results
|
|
|
|
|
|
|
|
|
|
|
Dollars in thousands, except EPS
|
|
|
Fiscal 2016
|
|
|
Fiscal 2015
|
|
|
|
Adjusted
|
|
As Reported
|
|
|
Adjusted
|
|
As Reported
|
|
|
|
(non-GAAP)
|
|
(GAAP)
|
|
|
(non-GAAP)
|
|
(GAAP)
|
Net Sales
|
|
|
$
|
76,650
|
|
|
$
|
76,650
|
|
|
|
$
|
90,779
|
|
|
$
|
90,779
|
|
Operating Income
|
|
|
|
7,916
|
|
|
|
7,320
|
|
|
|
|
5,392
|
|
|
|
2,819
|
|
Operating Margin
|
|
|
|
10.3
|
%
|
|
|
9.6
|
%
|
|
|
|
5.9
|
%
|
|
|
3.1
|
%
|
Net Income
|
|
|
|
4,978
|
|
|
|
4,591
|
|
|
|
|
2,857
|
|
|
|
1,185
|
|
Diluted EPS
|
|
|
$
|
0.42
|
|
|
$
|
0.39
|
|
|
|
$
|
0.24
|
|
|
$
|
0.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business segment results
Electronic Chemicals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter Results
|
|
|
|
|
|
|
Dollars in thousands
|
|
|
Fiscal 2016
|
|
|
Fiscal 2015
|
|
|
|
As Reported
|
|
|
As Reported
|
|
|
|
(GAAP)
|
|
|
(GAAP)
|
Net Sales
|
|
|
$
|
66,082
|
|
|
|
$
|
66,323
|
|
Operating Income
|
|
|
|
7,274
|
|
|
|
|
4,121
|
|
Operating Margin
|
|
|
|
11.0
|
%
|
|
|
|
6.2
|
%
|
|
|
|
|
|
|
|
For the first fiscal quarter, the Electronic Chemicals segment reported:
-
Sales of $66.1 million, essentially flat from the same period a year
ago despite the impact from the strong U.S. dollar, which reduced
sales by $3.0 million as compared to the prior year. Product volume
grew in North America and Asia, partially offset by softness in Europe.
-
GAAP operating income of $7.3 million vs. $4.1 million in the same
period of fiscal 2015. Operating income improved due to volume growth,
as well as operating efficiencies from the restructuring and
realignment of our electronic chemicals business.
-
EBITDA3 of $10.3 million, compared to $7.4 million last
year. Foreign currency translation reduced first quarter fiscal 2016
EBITDA by $277,000.
Other Chemicals
As of May 1, 2015, the Other Chemicals segment includes the
pentachlorophenol (“penta”) business and the industrial lubricants
business.
|
|
|
|
|
|
|
Other Chemicals
|
|
|
|
|
|
|
First Quarter Results
|
|
|
|
|
|
|
Dollars in thousands
|
|
|
Fiscal 2016
|
|
|
Fiscal 2015
|
|
|
|
As Reported
|
|
|
As Reported
|
|
|
|
(GAAP)
|
|
|
(GAAP)
|
Net Sales
|
|
|
$
|
10,568
|
|
|
|
$
|
24,427
|
|
Operating Income
|
|
|
|
3,764
|
|
|
|
|
2,585
|
|
Operating Margin
|
|
|
|
35.6
|
%
|
|
|
|
10.6
|
%
|
|
|
|
|
|
|
|
For the first fiscal quarter, the Other Chemicals segment reported:
-
Sales of $10.6 million compared to $24.4 million in the same period a
year ago. Sales declined due to the divestiture of the creosote
product line in fiscal 2015, partially offset by higher penta sales
and the addition of the industrial lubricants business.
-
GAAP operating income of $3.8 million, or 35.6% of sales, versus $2.6
million, or 10.6% of sales, last year. The increase in operating
income was due to higher penta shipment volume and the contribution
from the industrial lubricants business. Operating margins improved
due to higher penta volume, lower raw materials costs, the
contribution from the industrial lubricants business and the absence
of lower-margin creosote sales.
-
EBITDA4 of $4.0 million, up from $2.7 million last year.
Outlook
Our fiscal 2016 year is off to a strong start. We will review and update
our annual financial outlook at our customary time when we report our
second quarter results.
Conference call
Date: Thursday, December 10, 2015
Time:
5:00 p.m. ET
Dial in: 877-789-6981 or 541-797-2420
Conference
ID: 85516535
The conference call will be webcast live via the
“Investors” section of the Company’s website at http://kmgchemicals.com.
If you are unable to listen live, the conference call transcript will be
archived on the KMG website. A replay of the teleconference will also be
available for one week, starting at 8:00 p.m. ET on December 10, 2015.
To access the replay, call 855-859-2056 or 404-537-3406 using conference
ID 85516535.
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes
specialty chemicals to select markets. The Company grows by acquiring
and optimizing stable chemical product lines and businesses with
established production processes. For more information, visit the
Company's website at http://kmgchemicals.com.
The information in this news release includes certain forward-looking
statements that are based upon assumptions that in the future may prove
not to have been accurate and are subject to significant risks and
uncertainties, including statements as to the future performance of the
company. Although the company believes that the expectations reflected
in its forward-looking statements are reasonable, it can give no
assurance that such expectations or any of its forward-looking
statements will prove to be correct. Factors that could cause results to
differ include, but are not limited to, successful performance of
internal plans, product development acceptance, the impact of
competitive services and pricing and general economic risks and
uncertainties.
1 Non-U.S. GAAP measure. See Table 1 for reconciliation.
2 Non-U.S. GAAP measure. See Table 2 for reconciliation.
3 Non-U.S. GAAP measure. See Table 1 for reconciliation.
4 Non-U.S. GAAP measure. See Table 1 for reconciliation.
|
KMG CHEMICALS, INC. AND SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
|
(UNAUDITED)
|
(In thousands, except for per share amounts)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
October 31,
|
|
|
|
2015
|
|
|
2014
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
76,650
|
|
|
|
$
|
90,779
|
|
Cost of sales
|
|
|
|
47,390
|
|
|
|
|
63,188
|
|
Gross profit
|
|
|
|
29,260
|
|
|
|
|
27,591
|
|
|
|
|
|
|
|
|
Distribution expenses
|
|
|
|
10,129
|
|
|
|
|
12,999
|
|
Selling, general and administrative expenses
|
|
|
|
11,215
|
|
|
|
|
9,200
|
|
Restructuring charges
|
|
|
|
466
|
|
|
|
|
577
|
|
Realignment charges
|
|
|
|
130
|
|
|
|
|
1,996
|
|
Operating income
|
|
|
|
7,320
|
|
|
|
|
2,819
|
|
|
|
|
|
|
|
|
Other income (expense)
|
|
|
|
|
|
|
Interest expense, net
|
|
|
|
(152
|
)
|
|
|
|
(803
|
)
|
Other, net
|
|
|
|
(17
|
)
|
|
|
|
(28
|
)
|
Total other expense, net
|
|
|
|
(169
|
)
|
|
|
|
(831
|
)
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
7,151
|
|
|
|
|
1,988
|
|
Provision for income taxes
|
|
|
|
(2,560
|
)
|
|
|
|
(803
|
)
|
Net income
|
|
|
$
|
4,591
|
|
|
|
$
|
1,185
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
Net income per common share basic
|
|
|
$
|
0.39
|
|
|
|
$
|
0.10
|
|
Net income per common share diluted
|
|
|
$
|
0.39
|
|
|
|
$
|
0.10
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
Basic
|
|
|
|
11,697
|
|
|
|
|
11,658
|
|
Diluted
|
|
|
|
11,865
|
|
|
|
|
11,696
|
|
|
|
|
|
|
|
|
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
|
|
|
|
|
|
|
|
|
|
October 31,
|
|
|
July 31,
|
|
|
2015
|
|
|
2015
|
|
|
(Unaudited)
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
10,398
|
|
|
$
|
7,517
|
|
Accounts receivable
|
|
|
|
|
|
|
|
|
Trade, net of allowances of $156 at October 31, 2015 and $144
at July 31, 2015
|
|
|
35,573
|
|
|
|
36,887
|
|
Other
|
|
|
3,515
|
|
|
|
3,668
|
|
Inventories, net
|
|
|
39,592
|
|
|
|
42,082
|
|
Current deferred tax assets
|
|
|
2,953
|
|
|
|
2,953
|
|
Prepaid expenses and other
|
|
|
2,739
|
|
|
|
3,738
|
|
Total current assets
|
|
|
94,770
|
|
|
|
96,845
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
80,289
|
|
|
|
80,589
|
|
Deferred tax assets
|
|
|
131
|
|
|
|
131
|
|
Goodwill
|
|
|
22,374
|
|
|
|
22,408
|
|
Intangible assets, net
|
|
|
35,959
|
|
|
|
36,560
|
|
Restricted cash
|
|
|
1,000
|
|
|
|
1,000
|
|
Other assets, net
|
|
|
4,850
|
|
|
|
4,826
|
|
Total assets
|
|
$
|
239,373
|
|
|
$
|
242,359
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
27,279
|
|
|
$
|
35,980
|
|
Accrued liabilities
|
|
|
10,120
|
|
|
|
9,602
|
|
Employee incentive accrual
|
|
|
6,780
|
|
|
|
4,852
|
|
Total current liabilities
|
|
|
44,179
|
|
|
|
50,434
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
51,500
|
|
|
|
53,000
|
|
Deferred tax liabilities
|
|
|
13,145
|
|
|
|
13,075
|
|
Other long-term liabilities
|
|
|
2,422
|
|
|
|
2,429
|
|
Total liabilities
|
|
|
111,246
|
|
|
|
118,938
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity
|
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value, 10,000,000 shares authorized, none
issued
|
|
|
-
|
|
|
|
-
|
|
Common stock, $0.01 par value, 40,000,000 shares authorized,
|
|
|
|
|
|
|
|
|
11,710,439 shares issued and outstanding at October 31, 2015 and
|
|
|
|
|
|
|
|
|
11,690,439 shares issued and outstanding at July 31, 2015
|
|
|
117
|
|
|
|
117
|
|
Additional paid-in capital
|
|
|
32,625
|
|
|
|
31,676
|
|
Accumulated other comprehensive income (loss)
|
|
|
(10,151
|
)
|
|
|
(9,667
|
)
|
Retained earnings
|
|
|
105,536
|
|
|
|
101,295
|
|
Total stockholders’ equity
|
|
|
128,127
|
|
|
|
123,421
|
|
Total liabilities and stockholders’ equity
|
|
$
|
239,373
|
|
|
$
|
242,359
|
|
|
|
|
|
|
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
October 31,
|
|
|
|
|
2015
|
|
|
|
2014
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
$
|
4,591
|
|
|
$
|
1,185
|
|
Adjustments to reconcile net income to net cash provided by operating
activities
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
3,545
|
|
|
|
3,430
|
|
Non-cash restructuring and realignment charges
|
|
|
|
105
|
|
|
|
2,589
|
|
Amortization of loan costs
|
|
|
|
42
|
|
|
|
27
|
|
Stock-based compensation expense
|
|
|
|
939
|
|
|
|
436
|
|
Bad debt expense
|
|
|
|
12
|
|
|
|
-
|
|
Allowance for excess and obsolete inventory
|
|
|
|
57
|
|
|
|
221
|
|
Loss (gain) on disposal of property
|
|
|
|
9
|
|
|
|
(2
|
)
|
Deferred income taxes
|
|
|
|
86
|
|
|
|
(1,141
|
)
|
Tax benefit from stock-based awards
|
|
|
|
(10
|
)
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities, net of effects of
acquisition
|
|
|
|
|
|
|
|
|
|
Accounts receivable — trade
|
|
|
|
1,099
|
|
|
|
(2,398
|
)
|
Accounts receivable — other
|
|
|
|
160
|
|
|
|
(373
|
)
|
Inventories
|
|
|
|
2,310
|
|
|
|
(826
|
)
|
Other current and non-current assets
|
|
|
|
420
|
|
|
|
(139
|
)
|
Accounts payable
|
|
|
|
(7,850
|
)
|
|
|
4,486
|
|
Accrued liabilities and other
|
|
|
|
2,450
|
|
|
|
2,099
|
|
Net cash provided by operating activities
|
|
|
|
7,965
|
|
|
|
9,585
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
Additions to property, plant and equipment
|
|
|
|
(3,616
|
)
|
|
|
(4,184
|
)
|
Disposals of property, plant and equipment
|
|
|
|
-
|
|
|
|
10
|
|
Net cash used in investing activities
|
|
|
|
(3,616
|
)
|
|
|
(4,174
|
)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
Net payments under revolving credit agreement
|
|
|
|
-
|
|
|
|
(40,000
|
)
|
Principal payments on term loan
|
|
|
|
-
|
|
|
|
(20,000
|
)
|
Borrowings under New Credit Facility
|
|
|
|
-
|
|
|
|
59,100
|
|
Payments under New Credit Facility
|
|
|
|
(1,500
|
)
|
|
|
(3,100
|
)
|
Tax benefit from stock-based awards
|
|
|
|
10
|
|
|
|
9
|
|
Payment of dividends
|
|
|
|
(351
|
)
|
|
|
(349
|
)
|
Net cash used in financing activities
|
|
|
|
(1,841
|
)
|
|
|
(4,340
|
)
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
|
373
|
|
|
|
(592
|
)
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
|
2,881
|
|
|
|
479
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
7,517
|
|
|
|
19,252
|
|
Cash and cash equivalents at end of period
|
|
|
$
|
10,398
|
|
|
$
|
19,731
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of non-GAAP financial measures to GAAP financial
measures
KMG provides non-GAAP financial information to complement reported GAAP
results. KMG believes that analysis of our financial performance would
be enhanced by an understanding of the factors underlying that
performance and our judgments about the likelihood that particular
factors will repeat. We define adjusted EBITDA as earnings from
operations before interest, taxes, depreciation, amortization,
acquisition and integration expenses, restructuring and realignment
charges and other nonrecurring items.
KMG intends to continue to provide certain non-GAAP financial
information and the appropriate reconciliation to GAAP in its financial
results. As required by SEC rules, the tables below present a
reconciliation of our presented non-GAAP measures to the most directly
comparable GAAP measures. These non-GAAP measures should be viewed as a
supplement to, and not a substitute for, U.S. GAAP measures of
performance.
|
|
|
|
|
|
|
|
|
|
Table 1
RECONCILIATION OF OPERATING INCOME TO EBITDA AND ADJUSTED EBITDA
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
First Quarter Fiscal 2016
|
|
|
Electronic
|
|
Other
|
|
|
|
|
|
|
|
Chemicals
|
|
Chemicals
|
|
Corporate
|
|
Total
|
Operating Income (Loss)
|
|
|
$
|
7,274
|
|
$
|
3,764
|
|
|
|
($3,718
|
)
|
|
$
|
7,320
|
|
Other income (expense)
|
|
|
|
130
|
|
|
(59
|
)
|
|
|
(88
|
)
|
|
|
(17
|
)
|
Depreciation and amortization
|
|
|
|
2,915
|
|
|
297
|
|
|
|
439
|
|
|
|
3,651
|
|
EBITDA
|
|
|
|
10,319
|
|
|
4,002
|
|
|
|
(3,367
|
)
|
|
|
10,954
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring & realignment charges*
|
|
|
|
-
|
|
|
-
|
|
|
|
490
|
|
|
|
490
|
|
Adjusted EBITDA
|
|
|
|
10,319
|
|
|
4,002
|
|
|
|
(2,877
|
)
|
|
|
11,444
|
|
Corporate allocation
|
|
|
|
2,481
|
|
|
790
|
|
|
|
(3,271
|
)
|
|
|
-
|
|
Adjusted EBITDA excl. corporate allocation
|
|
|
$
|
12,800
|
|
$
|
4,792
|
|
|
|
($6,148
|
)
|
|
$
|
11,444
|
|
* Excludes depreciation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter Fiscal 2015
|
|
|
Electronic
|
|
Wood Treating
|
|
|
|
|
|
|
|
Chemicals
|
|
Chemicals
|
|
Corporate
|
|
Total
|
Operating Income (Loss)
|
|
|
$
|
4,121
|
|
$
|
2,585
|
|
|
|
($3,887
|
)
|
|
$
|
2,819
|
|
Other income (expense)
|
|
|
|
120
|
|
|
(10
|
)
|
|
|
(138
|
)
|
|
|
(28
|
)
|
Depreciation and amortization
|
|
|
|
3,202
|
|
|
96
|
|
|
|
2,721
|
|
|
|
6,019
|
|
EBITDA
|
|
|
|
7,443
|
|
|
2,671
|
|
|
|
(1,304
|
)
|
|
|
8,810
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring & realignment charges*
|
|
|
|
-
|
|
|
-
|
|
|
|
(16
|
)
|
|
|
(16
|
)
|
Adjusted EBITDA
|
|
|
|
7,443
|
|
|
2,671
|
|
|
|
(1,320
|
)
|
|
|
8,794
|
|
Corporate allocation
|
|
|
|
2,391
|
|
|
934
|
|
|
|
(3,325
|
)
|
|
|
-
|
|
Adjusted EBITDA excl. corporate allocation
|
|
|
$
|
9,834
|
|
$
|
3,605
|
|
|
$
|
(4,645
|
)
|
|
$
|
8,794
|
|
* Excludes depreciation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 2
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures to GAAP Financial
Measures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter Fiscal 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
Dollars in thousands, except EPS
|
|
|
KMG Chemicals, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
|
|
|
Net
|
|
|
Diluted Earnings
|
|
|
|
Income
|
|
|
Margin
|
|
|
Income
|
|
|
Per Share
|
Non-GAAP measure
|
|
|
$
|
7,916
|
|
|
|
10.3
|
%
|
|
|
$
|
4,978
|
|
|
|
$
|
0.42
|
|
Restructuring & realignment charges
|
|
|
|
(596
|
)
|
|
|
(0.8
|
%)
|
|
|
|
(387
|
)
|
|
|
|
($0.03
|
)
|
GAAP measure
|
|
|
$
|
7,320
|
|
|
|
9.5
|
%
|
|
|
$
|
4,591
|
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter Fiscal 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
Dollars in thousands, except EPS
|
|
|
KMG Chemicals, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
|
|
|
Net
|
|
|
Diluted Earnings
|
|
|
|
Income
|
|
|
Margin
|
|
|
Income
|
|
|
Per Share
|
Non-GAAP measure
|
|
|
$
|
5,392
|
|
|
|
5.9
|
%
|
|
|
$
|
2,857
|
|
|
|
$
|
0.24
|
|
Restructuring & realignment charges
|
|
|
|
(2,573
|
)
|
|
|
(2.8
|
%)
|
|
|
|
(1,672
|
)
|
|
|
|
($0.14
|
)
|
GAAP measure
|
|
|
$
|
2,819
|
|
|
|
3.1
|
%
|
|
|
$
|
1,185
|
|
|
|
$
|
0.10
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20151210006365/en/
Copyright Business Wire 2015